Novel Endoscopic Approaches to Treating Chronic Obstructive Pulmonary Disease and Emphysema

Abstract

Chronic obstructive pulmonary disease (COPD) is a widespread disease associated with high morbidity and mortality. The principal aim of therapy is preventing disease progression. Besides rehabilitation and pharmacological treatment, different endoscopic approaches were developed in the past decade extending the therapeutic spectrum. Various endoscopic lung volume reduction (ELVR) techniques are available that differ in the implementation, mechanism of action, complication spectrum, and reversibility. So far, the data on efficacy and safety are variable and still very limited. The most comprehensive data are available for endoscopic valve therapy. This reversible technique leads to lobar atelectasis and thus significant lobar volume reduction in patients with severe emphysema and low collateral ventilation. Implantation of coils leading to parenchymal compression and bronchoscopic thermal vapor ablation inducing an inflammatory reaction are nonblocking ELVR techniques and thus independent of collateral ventilation. Besides ELVR techniques, targeted lung denervation has evolved as the latest development in the field of endoscopic therapy in COPD. The aim of this endoscopic method is sustainable bronchodilation by minimizing the influence of parasympathetic pulmonary nerves on smooth muscles of the airways. This review summarizes the different endoscopic procedures, their mechanism of action, and the results of the clinical trials including efficacy and safety.

Keywords

endoscopic lung volume reduction - endoscopic valve therapy - thermal vapor ablation - collateral ventilation - emphysema - targeted lung denervation

• References

• 1 Gillissen AET. Weißbuch Lunge 2014. Herausforderungen, Zukunftsperspektiven, Forschungsansätze. Zur Lage und Zukunft der Pneumologie in Deutschland. Herne, Westf. FRISCHTEXTE Verlag; 2014
• 2 Murray CJ, Lopez AD. Measuring the global burden of disease. N Engl J Med 2013; 369 (5) 448-457
• 3 Global Strategy for the Diagnosis, Management and Prevention of COPD Global Initiative for Chronic Obstructive Lung Disease (GOLD); 2015
• 4 Fishman A, Martinez F, Naunheim K , et al; National Emphysema Treatment Trial Research Group. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med 2003; 348 (21) 2059-2073
• 5 Toma TP, Hopkinson NS, Hillier J , et al. Bronchoscopic volume reduction with valve implants in patients with severe emphysema. Lancet 2003; 361 (9361) 931-933
• 6 Snell GI, Holsworth L, Borrill ZL , et al. The potential for bronchoscopic lung volume reduction using bronchial prostheses: a pilot study. Chest 2003; 124 (3) 1073-1080
• 7 Sciurba FC, Ernst A, Herth FJF , et al; VENT Study Research Group. A randomized study of endobronchial valves for advanced emphysema. N Engl J Med 2010; 363 (13) 1233-1244
• 8 Herth FJ, Noppen M, Valipour A , et al; International VENT Study Group. Efficacy predictors of lung volume reduction with Zephyr valves in a European cohort. Eur Respir J 2012; 39 (6) 1334-1342
• 9 Gompelmann D, Eberhardt R, Michaud G, Ernst A, Herth FJF. Predicting atelectasis by assessment of collateral ventilation prior to endobronchial lung volume reduction: a feasibility study. Respiration 2010; 80 (5) 419-425
• 10 Herth FJ, Eberhardt R, Gompelmann D , et al. Radiological and clinical outcomes of using Chartis™ to plan endobronchial valve treatment. Eur Respir J 2013; 41 (2) 302-308
• 11 Gompelmann D, Eberhardt R, Slebos DJ , et al. Diagnostic performance comparison of the Chartis System and high-resolution computerized tomography fissure analysis for planning endoscopic lung volume reduction. Respirology 2014; 19 (4) 524-530
• 12 Ninane V, Geltner C, Bezzi M , et al. Multicentre European study for the treatment of advanced emphysema with bronchial valves. Eur Respir J 2012; 39 (6) 1319-1325
• 13 Eberhardt R, Gompelmann D, Schuhmann M, Heussel CP, Herth FJ. Complete unilateral vs partial bilateral endoscopic lung volume reduction in patients with bilateral lung emphysema. Chest 2012; 142 (4) 900-908
• 14 Gompelmann D, Herth FJF, Heussel CP, Hoffmann H, Dienemann H, Eberhardt R. Pneumothorax nach endoskopischer Ventiltherapie. Pneumologie 2014; 68 (S1): V454
• 15 Gompelmann D, Herth FJF, Slebos DJ , et al. Pneumothorax following endobronchial valve therapy and its impact on clinical outcomes in severe emphysema. Respiration 2014; 87 (6) 485-491
• 16 Herth FJ, Eberhard R, Gompelmann D, Slebos DJ, Ernst A. Bronchoscopic lung volume reduction with a dedicated coil: a clinical pilot study. Ther Adv Respir Dis 2010; 4 (4) 225-231
• 17 Slebos DJ, Klooster K, Ernst A, Herth FJ, Kerstjens HA. Bronchoscopic lung volume reduction coil treatment of patients with severe heterogeneous emphysema. Chest 2012; 142 (3) 574-582
• 18 Shah PL, Zoumot Z, Singh S , et al; RESET trial Study Group. Endobronchial coils for the treatment of severe emphysema with hyperinflation (RESET): a randomised controlled trial. Lancet Respir Med 2013; 1 (3) 233-240
• 19 Deslee G, Klooster K, Hetzel M , et al. Lung volume reduction coil treatment for patients with severe emphysema: a European multicentre trial. Thorax 2014; 69 (11) 980-986
• 20 Klooster K, Ten Hacken NH, Franz I, Kerstjens HA, van Rikxoort EM, Slebos DJ. Lung volume reduction coil treatment in chronic obstructive pulmonary disease patients with homogeneous emphysema: a prospective feasibility trial. Respiration 2014; 88 (2) 116-125
• 21 Kontogianni K, Gerovasili V, Gompelmann D , et al. Effectiveness of endobronchial coil treatment for lung volume reduction in patients with severe heterogeneous emphysema and bilateral incomplete fissures: a six-month follow-up. Respiration 2014; 88 (1) 52-60
• 22 Snell GI, Hopkins P, Westall G, Holsworth L, Carle A, Williams TJ. A feasibility and safety study of bronchoscopic thermal vapor ablation: a novel emphysema therapy. Ann Thorac Surg 2009; 88 (6) 1993-1998
• 23 Herth FJF, Eberhardt R, Ernst A , et al. The efficacy of bronchoscopic thermal vapor ablation in patients with upper lobe emphysema: the impact of heterogeneity of disease. Abstract 5167. ATS 2010; 5167
• 24 Snell G, Herth FJ, Hopkins P , et al. Bronchoscopic thermal vapour ablation therapy in the management of heterogeneous emphysema. Eur Respir J 2012; 39 (6) 1326-1333
• 25 Emery MJ, Eveland RL, Eveland K, Couetil LL, Hildebrandt J, Swenson ER. Lung volume reduction by bronchoscopic administration of steam. Am J Respir Crit Care Med 2010; 182 (10) 1282-1291
• 26 Herth FJ, Ernst A, Baker KM , et al. Characterization of outcomes 1 year after endoscopic thermal vapor ablation for patients with heterogeneous emphysema. Int J Chron Obstruct Pulmon Dis 2012; 7: 397-405
• 27 Gompelmann D, Eberhardt R, Ernst A , et al. The localized inflammatory response to bronchoscopic thermal vapor ablation. Respiration 2013; 86 (4) 324-331
• 28 Gompelmann D, Heussel CP, Eberhardt R , et al. Efficacy of bronchoscopic thermal vapor ablation and lobar fissure completeness in patients with heterogeneous emphysema. Respiration 2012; 83 (5) 400-406
• 29 Valipour A, Pison C, Kessler R, Deslee G. Bilateral targeted lung denervation in patients with COPD in a single procedure. Abstract 1775; ERS 2014
• 30 Slebos DJ, Klooster K, Koegelenberg C , et al. Efficacy of targeted lung denervation in patients with moderate to severe COPD. Abstract 1774; ERS 2014